Rockwell Medical (RMTI) Tops Q2 EPS by 4c ; offers guidance
Tweet
Share
E-mailGet Alerts RMTI Hot Sheet
Price: $0.68 --0%
Revenue Growth %: +10.8%
Financial Fact:
Diluted Earnings (Loss) per Share: -0.09
Today's EPS Names:
YRD, NNOX, BB, More
Revenue Growth %: +10.8%
Financial Fact:
Diluted Earnings (Loss) per Share: -0.09
Today's EPS Names:
YRD, NNOX, BB, More
Join SI Premium – FREE
Rockwell Medical (NASDAQ: RMTI) reported Q2 EPS of ($0.01), $0.04 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $16.1 million versus the consensus estimate of $16.33 million.
GUIDANCE:
Rockwell Medical sees FY2025 revenue of $65-70 million, versus the consensus of $68.23 million.
For earnings history and earnings-related data on Rockwell Medical (RMTI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs (GS) Reiterated at Market Perform by Citizens on Constructive Backdrop
- Qualcomm expects $40bn in non-handset revenue by fiscal 2029
- Deutsche Bank Downgrades Man Group Plc. (EMG:LN) (MNGPY) to Hold
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
